Abstract
The human health benefits attributed to turmeric/curcumin spice has resulted in its wide utilization as a dietary supplement for companion pets and other animals including horses. While the quantification of free curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and their phase-2 metabolites (curcumin-O-sulfate, curcumin-O-glucuronide) have been extensively investigated in human and rodent biological samples (primarily plasma and serum), there is lack of similar data for horses. Herein, we report a validated LC-ESI–MS/MS method for the simultaneous quantification of the aforementioned free curcuminoids and their metabolites in equine plasma. The linearity of the aforementioned curcuminoids and curcumin-O-sulfate was in the range of 0.5–1000 ng/mL and 1–1000 ng/mL for curcumin-O-glucuronide with 85–115% accuracy and <15% precision in equine plasma. The method was validated based on US FDA criteria and applied to characterize the pharmacokinetics of curcumin-O-sulfate in equine plasma.
Original language | English |
---|---|
Pages (from-to) | 31-39 |
Number of pages | 9 |
Journal | Journal of Pharmaceutical and Biomedical Analysis |
Volume | 154 |
DOIs | |
State | Published - May 30 2018 |
Bibliographical note
Publisher Copyright:© 2018 Elsevier B.V.
Funding
This project was conducted using a mass spectrometry instrument located in the Rhode Island NSF EPSCoR research facility, supported in part by the National Science Foundation EPSCoR Cooperative Agreement #EPS-1004057.
Funders | Funder number |
---|---|
National Science Foundation/EPSCoR | -1004057 |
Rhode Island NSF EPSCoR |
Keywords
- Curcuminoids
- Equine
- LC–MS/MS
- Metabolites
- Pharmacokinetics
- Plasma
ASJC Scopus subject areas
- Analytical Chemistry
- Pharmaceutical Science
- Drug Discovery
- Spectroscopy
- Clinical Biochemistry